Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11250296 | PMC |
| http://dx.doi.org/10.21037/qims-24-134 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correlation between sonographic classification and the efficacy of microwave ablation for adenomyosis.
Quant Imaging Med Surg
December 2024
Department of Ultrasound, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Background: Adenomyosis is a common benign gynecological disease. Patients often experience abnormal uterine bleeding, dysmenorrhea, and infertility. Percutaneous microwave ablation (PMWA) is a minimally invasive method used for treating adenomyosis while preserving the uterus.
View Article and Find Full Text PDFImaging Classification of Exophytic HCC and Our Experience with Microwave Ablation of Type 2 Lesions.
Indian J Radiol Imaging
January 2025
Department of Interventional Radiology, Medanta-The Medicity, Gurugram, Haryana, India.
The purpose of this article is to classify hepatocellular carcinoma (HCC) based on imaging and to evaluate the role of ultrasound-guided microwave ablation (MWA) in the management of type 2 exophytic HCC. A retrospective study was performed at our institution after approval by the Institutional Review Board. The study was undertaken from January 2017 to May 2022.
View Article and Find Full Text PDFUltrasound guided microwave ablation treatment of uterine fibroids: Clinical response and patient acceptability.
Acta Obstet Gynecol Scand
December 2024
Department of Obstetrics and Gynecology, Danderyd Hospital, Stockholm, Sweden.
Introduction: The objective of this study was to evaluate the effectiveness and acceptability of ultrasound guided microwave ablation for treating symptoms related to uterine fibroids.
Material And Methods: This was a prospective interventional study. Patients with symptomatic uterine fibroids were included at Danderyd Hospital, Sweden, from January 2020 to August 2023.
Objective: To evaluate the therapeutic effects of microwave ablation (MWA) versus surgery in treating low-risk papillary thyroid microcarcinoma (PTMC) and to assess recurrence-free survival (RFS) in patients with and without the BRAFV600E mutation.
Methods: Between August 2016 and September 2022, 158 patients diagnosed with low-risk PTMC treated with MWA and 288 patients who underwent surgical treatment were retrospectively analyzed. All patients were followed-up for over a year.
Ultrasound-based radiomics to predict the volume reduction rate of benign thyroid nodules after microwave ablation.
Endocrine
December 2024
Department of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Objective: To evaluate the predictive power of ultrasound-based radiomics models for benign thyroid nodules with a volume reduction rate (VRR) of < or ≥75% at 12 months after microwave ablation.
Methods: A retrospective study was conducted on 194 individuals with benign thyroid nodules who received ultrasound-guided microwave ablation between November 2019 and June 2023. The clinical and ultrasound features, including age, gender, volume, echogenicity, duration of ablation, and so on were analysed by t-test or chi-square test.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!